2026年全球性傳染病診斷市場報告

近年來，性行為感染（STI）診斷市場發展迅速，預計將從2025年的107.7億美元成長到2026年的119.1億美元，複合年成長率（CAGR）為10.6%。過去幾年的成長可歸因於性行為感染的增加、診斷檢測機構的擴張、公共衛生篩檢計畫的擴展、性健康意識提升以及先進核酸檢測技術的廣泛應用。

預計未來幾年，性性行為感染）診斷市場將快速成長，到2030年市場規模將達到175.2億美元，複合年成長率（CAGR）為10.1%。預測期內的成長可歸因於對快速診斷需求的增加、家用檢測套組的普及、分子診斷技術的滲透率提高、公共衛生監測投入的增加以及對保密性和便捷性檢測服務的日益重視。預測期內的主要趨勢包括：快速和照護現場（POC​​）性行為感染檢測的普及、分子診斷技術的廣泛應用、自動化檢測系統的整合度不斷提高、家用性性行為感染檢測解決方案的擴展以及對早期準確疾病檢測的日益重視。

預計未來幾年，性行為感染發生率的上升將推動性傳染性行為感染）診斷領域的擴張。性行為感染主要透過性接觸傳播，需要及時進行醫學檢測和臨床治療。這些感染疾病的上升趨勢主要歸因於年輕人性行為的活性化和社會行為的改變。性健康污名化的減少和流動性的增強促進了性網路的擴張，也增加了感染風險。隨著醫療機構擴大採用複雜的檢測方法、篩檢工具和先進的檢測技術來進行早期發現和預防感染，這種上升趨勢直接推動了對診斷解決方案的需求。例如，根據美國疾病管制與預防中心（CDC）2025年9月發布的數據，先天性梅毒病例數預計將連續第12年增加，到2024年將達到約4,000例通報病例。因此，性傳染感染性行為感染傳染病診斷市場的成長。

為了滿足未被滿足的醫療需求並提高診斷能力，性行為感染診斷市場的主要企業正致力於開發創新產品，例如即時PCR試劑盒。即時PCR試劑盒包含一組用於進行即時聚合酵素鏈鎖反應（qPCR）的試劑，qPCR是一種高靈敏度且應用廣泛的檢測和定量特定核酸序列的技術。例如，2023年3月，中國研發公司江蘇博奧菲斯科技有限公司推出了“黴漿菌即時PCR試劑盒”和“梅毒螺旋體即時PCR試劑盒”，分別用於檢測黴漿菌和梅毒螺旋體。這些試劑盒具有高靈敏度和特異性、操作簡便、快速出結果以及單次檢測多種病原體的能力。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球性傳染病診斷市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 人工智慧（AI）和自主人工智慧
  • 生物技術、基因組學和精準醫學
  • 數位化、雲端運算、巨量資料、網路安全
  • 物聯網、智慧基礎設施和互聯生態系統
  • 工業4.0和智慧製造
• 主要趨勢
  • 擴大快速、照護現場性行為感染檢測的應用
  • 擴大分子診斷技術的應用
  • 自動化檢測系統整合的進展
  • 擴大居家性性行為感染檢測方案
  • 人們越來越重視疾病的早期準確檢測

第5章 終端用戶產業市場分析

• 醫院
• 診所
• 診斷中心
• 公共衛生研究所
• 家庭檢測服務提供者

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球性傳染病診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 全球性傳染病診斷市場規模、對比及成長率分析
• 全球性傳染病診斷市場表現：規模與成長，2020-2025年
• 全球性傳染病診斷市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 按類型
• 披衣菌感染檢測、梅毒檢測、淋病檢測、單純皰疹病毒檢測、人類乳突病毒檢測、人類免疫力缺乏病毒檢測、軟性下疳檢測
• 通過測試施行地點
• 檢查室、照護現場檢測（PoC）
• 最終用戶
• 醫院、診所、診斷中心、居家醫療
• 按類型細分：披衣菌感染檢測
• 核酸增幅檢查（NAAT）、抗原檢測
• 按類型細分：梅毒檢測
• 快速血漿反應 (RPR) 試驗、密螺旋體試驗
• 按類型細分：淋病檢測
• 核酸增幅檢查（NAATs）、培養檢測
• 按類型細分：單純皰疹病毒檢測
• PCR檢測、血清學檢測
• 按類型細分：人類乳突病毒檢測
• HPV DNA檢測，HPV RNA檢測
• 按類型細分：人類免疫力缺乏病毒檢測
• 抗體檢測、抗原或抗體檢測、核酸增幅檢查（NAT）
• 按類型細分：軟性下疳檢查
• 培養檢測、核酸檢測

第10章 區域與國家分析

• 全球性傳染病診斷市場：區域表現及預測，2020-2025年、2025-2030年預測、2035年預測
• 全球性傳染病診斷市場：按國家/地區分類，實際值和預測值，2020-2025 年、2025-2030 年預測值、2035 年預測值

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 性傳染病診斷市場：競爭格局及市場佔有率（2024年）
• 性傳染病診斷市場：公司估值矩陣
• 性傳染病診斷市場：公司概況
  • Abbott Laboratories
  • Qiagen Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Hologic Inc.

第37章：其他領先和創新企業

• Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMerieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年性傳染病診斷市場：提供新機會的國家
• 2030年性傳染病診斷市場：新興細分市場機會
• 2030年性傳染病診斷市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Sexually Transmitted Diseases (STDs) diagnostics encompass the examination and identification of infectious conditions transmitted through sexual contact. These diagnostic procedures are essential in determining the presence of STDs within an individual.

The primary categories of STD diagnostics include chlamydia, syphilis, gonorrhea, herpes simplex virus, human papillomavirus, human immunodeficiency virus, chancroid, and other tests performed in laboratory and point-of-care settings. Chlamydia testing involves a urine sample analysis to detect infection. This specific test is employed for identifying chlamydia infections, a common bacterial sexually transmitted infection (STI) transmitted through various forms of sexual contact or genital exposure. These STD diagnostic procedures find application in hospitals, clinics, diagnostic centers, and homecare settings.

Tariffs are influencing the std diagnostics market by increasing costs of imported reagents, assay kits, diagnostic instruments, and molecular testing components used in laboratory and point-of-care settings. Healthcare providers in North America and Europe are most affected due to reliance on imported test kits, while Asia-Pacific faces higher manufacturing and export costs. These tariffs are raising testing prices and affecting screening program budgets. At the same time, they are supporting local reagent production, domestic diagnostic manufacturing, and regional supply chain strengthening.

The std diagnostics market research report is one of a series of new reports from The Business Research Company that provides std diagnostics market statistics, including std diagnostics industry global market size, regional shares, competitors with a std diagnostics market share, detailed std diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the std diagnostics industry. This std diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The std diagnostics market size has grown rapidly in recent years. It will grow from $10.77 billion in 2025 to $11.91 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing prevalence of sexually transmitted infections, expansion of diagnostic laboratory infrastructure, growing public health screening programs, rising awareness of sexual health, availability of advanced nucleic acid testing.

The std diagnostics market size is expected to see rapid growth in the next few years. It will grow to $17.52 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostics, rising adoption of home-based testing kits, expansion of molecular diagnostics penetration, growing investments in public health surveillance, increasing focus on confidential and accessible testing services. Major trends in the forecast period include increasing adoption of rapid and point-of-care std tests, rising use of molecular diagnostic technologies, growing integration of automated laboratory systems, expansion of at-home std testing solutions, enhanced focus on early and accurate disease detection.

The increasing incidence of sexually transmitted diseases is expected to drive the expansion of the STD diagnostics sector in the coming years. Sexually transmitted diseases are infections spread primarily through sexual contact and require timely medical testing and clinical management. The rising burden of these infections is largely attributed to higher levels of sexual activity and evolving social behaviors among younger populations, where reduced stigma around sexual health and increased mobility have contributed to broader sexual networks and elevated transmission risks. This growing prevalence directly fuels demand for diagnostic solutions, as healthcare providers increasingly rely on precise laboratory assays, screening tools, and advanced detection technologies to identify infections early and limit further spread. For example, in September 2025, data from the Centers for Disease Control and Prevention indicated that cases of congenital syphilis increased for the twelfth consecutive year, reaching nearly 4,000 reported cases in 2024. As a result, the rising prevalence of sexually transmitted diseases is contributing significantly to the growth of STD diagnostics.

Key companies in the STD diagnostics market are focusing on developing innovative products, such as real-time PCR kits, to meet unmet medical needs and improve diagnostic capabilities. A real-time PCR kit consists of a collection of reagents utilized for conducting real-time polymerase chain reaction (qPCR), a sensitive and commonly employed technique for detecting and quantifying specific nucleic acid sequences. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based research and development company, introduced the Mycoplasma Hominis Real Time PCR Kit and the Treponema Pallidum Real Time PCR Kit, specifically designed for detecting Mycoplasma hominis and Treponema pallidum. These kits offer high sensitivity and specificity, user-friendliness, rapid turnaround times, and the capability to detect multiple pathogens in a single test.

In February 2024, Thyrocare, an India-based healthcare company, acquired Think Health Care for an undisclosed amount. With this acquisition, Thyrocare aims to strategically enhance its service offerings and market reach, especially in the home healthcare segment. Think Health Care is an India-based company specializing in diagnostic and preventive healthcare, known for providing at-home ECG services.

Major companies operating in the std diagnostics market are Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMerieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

North America was the largest region in the STD diagnostics market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the std diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the std diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The STD diagnostics market consists of revenues earned by entities by providing STD diagnostics tests such as cultural/isolated tests of organisms, molecular tests, and immunology assays. The market value includes the value of related goods sold by the service provider or included within the service offering. The STD diagnostics market also includes sales of thermal cyclers, PCR, lateral flow readers - immuno chromatographic assays, flow cytometers, differential light scattering machines, absorbance microplate readers, phone chips, and rapid diagnostic kits which are used in providing STD diagnostic services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

STD Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses std diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for std diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The std diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Chlamydia Testing; Syphilis Testing; Gonorrhea Testing; Herpes Simplex Virus Testing; Human Papilloma Virus Testing; Human Immunodeficiency Virus Testing; Chancroid Testing
• 2) By Location Of Testing: Laboratory Testing; Point Of Care (PoC) Testing
• 3) By End-User: Hospitals And Clinics; Diagnostic Centers; Homecare
• Subsegments:
• 1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT); Antigen Tests
• 2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests; Treponemal Tests
• 3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT); Culture Tests
• 4) By Herpes Simplex Virus Testing: PCR Tests; Serological Tests
• 5) By Human Papilloma Virus Testing: HPV DNA Tests; HPV RNA Tests
• 6) By Human Immunodeficiency Virus Testing: Antibody Tests; Antigen Or Antibody Tests; Nucleic Acid Tests (NAT)
• 7) By Chancroid Testing: Culture Tests; Nucleic Acid Tests
• Companies Mentioned: Abbott Laboratories; Qiagen Inc.; Danaher Corporation; F. Hoffmann-La Roche AG; Hologic Inc.; Bio-Rad Laboratories Inc.; Becton Dickinson and Company; Thermo Fisher Scientific Inc.; Biocartis NV; Trinity Biotech PLC; Binx Health Inc.; NOWDiagnostics Inc.; Atlas Genetics Ltd.; BioFire Diagnostics LLC; BioMerieux SA; Chembio Diagnostic Systems Inc.; Corgenix Medical Corporation; Creative Diagnostics; Curetis AG; Daktari Diagnostics; Enzo Biochem Inc.; Fujirebio Diagnostics Inc.; GenePOC Inc.; GenMark Diagnostics Inc.; Grifols Diagnostic Solutions Inc.; Hain Lifescience GmbH; Luminex Corporation; Meridian Bioscience Inc.; Mesa Biotech Inc.; Mobidiag Oy
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. STD Diagnostics Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global STD Diagnostics Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. STD Diagnostics Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global STD Diagnostics Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Rapid And Point-Of-Care Std Tests
  • 4.2.2 Rising Use Of Molecular Diagnostic Technologies
  • 4.2.3 Growing Integration Of Automated Laboratory Systems
  • 4.2.4 Expansion Of At-Home Std Testing Solutions
  • 4.2.5 Enhanced Focus On Early And Accurate Disease Detection

5. STD Diagnostics Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Diagnostic Centers
• 5.4 Public Health Laboratories
• 5.5 Homecare Testing Providers

6. STD Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global STD Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global STD Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global STD Diagnostics Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global STD Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global STD Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global STD Diagnostics Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. STD Diagnostics Market Segmentation

• 9.1. Global STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing
• 9.2. Global STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Laboratory Testing, Point Of Care (PoC) Testing
• 9.3. Global STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Diagnostic Centers, Homecare
• 9.4. Global STD Diagnostics Market, Sub-Segmentation Of Chlamydia Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Nucleic Acid Amplification Tests (NAAT), Antigen Tests
• 9.5. Global STD Diagnostics Market, Sub-Segmentation Of Syphilis Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Rapid Plasma Reagin (RPR) Tests, Treponemal Tests
• 9.6. Global STD Diagnostics Market, Sub-Segmentation Of Gonorrhea Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Nucleic Acid Amplification Tests (NAAT), Culture Tests
• 9.7. Global STD Diagnostics Market, Sub-Segmentation Of Herpes Simplex Virus Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• PCR Tests, Serological Tests
• 9.8. Global STD Diagnostics Market, Sub-Segmentation Of Human Papilloma Virus Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• HPV DNA Tests, HPV RNA Tests
• 9.9. Global STD Diagnostics Market, Sub-Segmentation Of Human Immunodeficiency Virus Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antibody Tests, Antigen Or Antibody Tests, Nucleic Acid Tests (NAT)
• 9.10. Global STD Diagnostics Market, Sub-Segmentation Of Chancroid Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Culture Tests, Nucleic Acid Tests

10. STD Diagnostics Market Regional And Country Analysis

• 10.1. Global STD Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global STD Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific STD Diagnostics Market

• 11.1. Asia-Pacific STD Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China STD Diagnostics Market

• 12.1. China STD Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India STD Diagnostics Market

• 13.1. India STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan STD Diagnostics Market

• 14.1. Japan STD Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia STD Diagnostics Market

• 15.1. Australia STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia STD Diagnostics Market

• 16.1. Indonesia STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea STD Diagnostics Market

• 17.1. South Korea STD Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan STD Diagnostics Market

• 18.1. Taiwan STD Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia STD Diagnostics Market

• 19.1. South East Asia STD Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe STD Diagnostics Market

• 20.1. Western Europe STD Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK STD Diagnostics Market

• 21.1. UK STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany STD Diagnostics Market

• 22.1. Germany STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France STD Diagnostics Market

• 23.1. France STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy STD Diagnostics Market

• 24.1. Italy STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain STD Diagnostics Market

• 25.1. Spain STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe STD Diagnostics Market

• 26.1. Eastern Europe STD Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia STD Diagnostics Market

• 27.1. Russia STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America STD Diagnostics Market

• 28.1. North America STD Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA STD Diagnostics Market

• 29.1. USA STD Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada STD Diagnostics Market

• 30.1. Canada STD Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America STD Diagnostics Market

• 31.1. South America STD Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil STD Diagnostics Market

• 32.1. Brazil STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East STD Diagnostics Market

• 33.1. Middle East STD Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa STD Diagnostics Market

• 34.1. Africa STD Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. STD Diagnostics Market Regulatory and Investment Landscape

36. STD Diagnostics Market Competitive Landscape And Company Profiles

• 36.1. STD Diagnostics Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. STD Diagnostics Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. STD Diagnostics Market Company Profiles
  • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Qiagen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

37. STD Diagnostics Market Other Major And Innovative Companies

• Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMerieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics

38. Global STD Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The STD Diagnostics Market

40. STD Diagnostics Market High Potential Countries, Segments and Strategies

• 40.1 STD Diagnostics Market In 2030 - Countries Offering Most New Opportunities
• 40.2 STD Diagnostics Market In 2030 - Segments Offering Most New Opportunities
• 40.3 STD Diagnostics Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer